The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro

First Page		Document Content
Syndromes Seizure types Neurological disorders Epilepsy Rett syndrome CDKL5 Ohtahara syndrome MECP2 West syndrome Health Brain Central nervous system		The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro Add to Reading List Source URL: www.biomedcentral.com Download Document from Source Website File Size: 200,63 KB Share Document on Facebook

	The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy DocID: 1pzu2 - View Document
	Hindawi Publishing Corporation Epilepsy Research and Treatment Volume 2013, Article ID[removed], 9 pages http://dx.doi.org[removed][removed]Review Article DocID: QInW - View Document
	Microsoft PowerPoint - 01 Mikati_opening_remarks.pptx DocID: HQnH - View Document
	The Importance of Clinical Research in Pediatric Epilepsy Setting Priorities & Building a National Infrastructure Anne T. Berg, Ph.D. Lurie Children’s Hospital DocID: HfLB - View Document
	The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro DocID: HdUp - View Document